BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 18375894)

  • 1. Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626.
    Goodwin JW; Green SJ; Moinpour CM; Bearden JD; Giguere JK; Jiang CS; Lippman SM; Martino S; Albain KS
    J Clin Oncol; 2008 Apr; 26(10):1650-6. PubMed ID: 18375894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen.
    Kimmick GG; Lovato J; McQuellon R; Robinson E; Muss HB
    Breast J; 2006; 12(2):114-22. PubMed ID: 16509835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms.
    Sestak I; Kealy R; Edwards R; Forbes J; Cuzick J
    J Clin Oncol; 2006 Aug; 24(24):3991-6. PubMed ID: 16921052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Femal, a herbal remedy made from pollen extracts, reduces hot flushes and improves quality of life in menopausal women: a randomized, placebo-controlled, parallel study.
    Winther K; Rein E; Hedman C
    Climacteric; 2005 Jun; 8(2):162-70. PubMed ID: 16096172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1.
    Pockaj BA; Gallagher JG; Loprinzi CL; Stella PJ; Barton DL; Sloan JA; Lavasseur BI; Rao RM; Fitch TR; Rowland KM; Novotny PJ; Flynn PJ; Richelson E; Fauq AH
    J Clin Oncol; 2006 Jun; 24(18):2836-41. PubMed ID: 16782922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial.
    Speroff L; Gass M; Constantine G; Olivier S;
    Obstet Gynecol; 2008 Jan; 111(1):77-87. PubMed ID: 18165395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer.
    Osborne CR; Duncan A; Sedlacek S; Paul D; Holmes F; Vukelja S; Kasper M; Wilks S; Schneider A; McGee R; Meyer WG; O'Shaughnessy JA
    Breast Cancer Res Treat; 2009 Aug; 116(3):521-7. PubMed ID: 19139988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes.
    Quella SK; Loprinzi CL; Sloan JA; Vaught NL; DeKrey WL; Fischer T; Finck G; Pierson N; Pisansky T
    Cancer; 1998 May; 82(9):1784-8. PubMed ID: 9576302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Megestrol acetate for the prevention of hot flashes.
    Loprinzi CL; Michalak JC; Quella SK; O'Fallon JR; Hatfield AK; Nelimark RA; Dose AM; Fischer T; Johnson C; Klatt NE
    N Engl J Med; 1994 Aug; 331(6):347-52. PubMed ID: 8028614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.
    Reed SD; Newton KM; LaCroix AZ; Grothaus LC; Grieco VS; Ehrlich K
    Menopause; 2008; 15(1):51-8. PubMed ID: 18257142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying meaningful differences in vasomotor symptoms among menopausal women.
    Wyrwich KW; Spratt DI; Gass M; Yu H; Bobula JD
    Menopause; 2008; 15(4 Pt 1):698-705. PubMed ID: 18369313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patients.
    Deng G; Vickers A; Yeung S; D'Andrea GM; Xiao H; Heerdt AS; Sugarman S; Troso-Sandoval T; Seidman AD; Hudis CA; Cassileth B
    J Clin Oncol; 2007 Dec; 25(35):5584-90. PubMed ID: 18065731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desvenlafaxine for the treatment of vasomotor symptoms associated with menopause: a double-blind, randomized, placebo-controlled trial of efficacy and safety.
    Archer DF; Dupont CM; Constantine GD; Pickar JH; Olivier S;
    Am J Obstet Gynecol; 2009 Mar; 200(3):238.e1-238.e10. PubMed ID: 19167693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sertraline to treat hot flashes: a randomized controlled, double-blind, crossover trial in a general population.
    Gordon PR; Kerwin JP; Boesen KG; Senf J
    Menopause; 2006; 13(4):568-75. PubMed ID: 16837878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is megestrol acetate a suitable option for treatment of hot flashes in women with breast cancer?
    Warren MP
    Nat Clin Pract Endocrinol Metab; 2008 Dec; 4(12):650-1. PubMed ID: 18825137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study.
    Swanson SG; Drosman S; Helmond FA; Stathopoulos VM
    Menopause; 2006; 13(6):917-25. PubMed ID: 17006377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pomegranate seed oil in women with menopausal symptoms: a prospective randomized, placebo-controlled, double-blinded trial.
    Auerbach L; Rakus J; Bauer C; Gerner C; Ullmann R; Wimmer H; Huber J
    Menopause; 2012 Apr; 19(4):426-32. PubMed ID: 22240636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen for one year versus two years versus 6 months of Tamoxifen and 6 months of megestrol acetate: a randomized comparison in postmenopausal patients with high-risk breast cancer (DBCG 89C).
    Andersen J; Kamby C; Ejlertsen B; Cold S; Ewertz M; Jacobsen EH; Philip P; Møller KA; Jensen D; Møller S
    Acta Oncol; 2008; 47(4):718-24. PubMed ID: 18465340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users.
    Decensi A; Gandini S; Serrano D; Cazzaniga M; Pizzamiglio M; Maffini F; Pelosi G; Daldoss C; Omodei U; Johansson H; Macis D; Lazzeroni M; Penotti M; Sironi L; Moroni S; Bianco V; Rondanina G; Gjerde J; Guerrieri-Gonzaga A; Bonanni B
    J Clin Oncol; 2007 Sep; 25(27):4201-9. PubMed ID: 17709798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial.
    Bachmann GA; Schaefers M; Uddin A; Utian WH
    Obstet Gynecol; 2007 Oct; 110(4):771-9. PubMed ID: 17906008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.